Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
| Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments |
| Autore | Uchino Junji |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (258 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adjuvant chemotherapy
biomarker chemotherapy daily practice DNA polymerase beta docetaxel EGFR-TKI endocrine disorders epidermal growth factor receptor Expanded Access Program FDG-PET genomic diagnosis glucose transporter 1 HIP1R immune checkpoint inhibitor immune checkpoint inhibitors immune-related adverse events immunotherapy interstitial lung disease KRAS lung cancer lung neoplasms meta-analysis metastasis methylation multiple cancers mutation network meta-analysis nivolumab non-small cell lung cancer non-small-cell lung cancer nonsmall cell lung cancer NSCLC nucleotide-diphosphate kinase oligometastasis osimertinib PD-1 PD-1 blockade PD-1 inhibitors PD-L1 PD-L1 expression PD-L1 inhibitors phase I/II trial platinum-based first-line predictive biomarker previously treated patients prognosis prognostic factor prognostic factors pulmonary fibrosis pulmonary pleomorphic carcinoma RAD51B methylation radiology and other imaging real-world data rechallenge recurrence responsiveness retrospective analysis RUNX1 S-1 salvage surgery sequencing stage IIIA-N2 surgery survival T790M targeted therapy TP53 mutations tumor-bearing patients tyrosine kinase inhibitors unresectable β-catenin |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Non-small Cell Lung Cancer |
| Record Nr. | UNINA-9910557489703321 |
Uchino Junji
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Precision Medicine in Solid Tumors
| Precision Medicine in Solid Tumors |
| Autore | Dey Nandini |
| Descrizione fisica | 1 online resource (304 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
adjuvant chemotherapy
anaplastic lymphoma receptor tyrosine kinase breast cancer cancer cancer-associated fibroblasts cfDNA chemotherapy circulating free DNA clinical guideline clonality classification comprehensive genomic profiling CTC ctDNA DDR genes Decision tree digital enrichment driver mutation EGFR mutation EGFR-TKI electronic records epidermal growth factor receptor extent of resection gene panel sequencing glioblastoma prognosis HNSCC immune checkpoint inhibitors immunocytochemistry immunotherapy intratumor heterogeneity laboratory-friendly liquid biopsy molecular barcoding molecular genotyping multiple biopsies n/a new drug development next-generation sequencing next-generation sequencing (NGS) NGS non-small cell lung cancer open data osimertinib outcome overall survival parallel double-detection PARP inhibitors PD-L1 pediatric tumors personalized precision oncology precision medicine presumed germline findings random forest regulatory reform resistance screening sequencing smoking solid cancer strategic therapeutic intervention targeted therapy tDNA thymoma TMB TNBC subtypes triple-negative breast cancer (TNBC) tumor evolution tumor mutational burden tumor profiling test tyrosine kinase inhibitor universal health-care system whole-exome sequencing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910595078103321 |
|
Dey Nandini
|
||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||